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Medicine, Edgewood, United States; 2ICON Late Phase & Outcomes Research,
San Francisco, United States
Objectives: Studies have demonstrated that CF infants without respiratory signs and
symptoms commonly have lung disease markers including inﬂammation, bronchial
wall thickening, reduced ﬂow, and ventilation inhomogeneity. However, a majority
of CF 6-year-olds have an FEV1 >90% predicted, which might be considered
‘normal’ and suggest that only a minority of these children have diminished FEV1.
Methods: Stanojevic FEV1 % predicted and Z-score distributions were determined
for 686 6-year olds (362 males) from Austria, Belgium, Czech Republic, Germany,
Denmark, France, Greece, Hungary, Israel, Italy, The Netherlands, Portugal, and
Slovenia followed in the ECFS Registry. Observed Z-scores were plotted against
theoretical values based on the Normal distribution.
Conclusions: The population FEV1 % predicted was 91.6% (SD = 17.9). More
than twice as many children had FEV1 Z-scores <−1 than predicted for the
normative population (38.0% versus 15.9%), with a quarter fewer patients having
Z-scores >−1. Quantile-quantile plots revealed that FEV1 Z-scores were consis-
tently lower than expected, suggesting that most, if not all, CF children have
diminished lung function by age 6, including those patients with apparently ‘normal’
FEV1 % predicted values (Z-scores >−1). Strategies emphasizing treatment of the
minority of CF infants with respiratory signs and symptoms may be inadequate to
reduce lung disease progression in the population. Quantile-quantile plots may prove
useful for evaluating future population changes in CF lung disease progression.
WS12.2 The impact of switching to the new global lung function
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Background: The new Global Lung Function Initiative (GLI) all-age spirometry
reference equations have recently been endorsed by all international respiratory
societies, and are now considered the international gold standard (Quanjer et al; Eur
Resp J 2012, www.lungfunction.org). The UK CF Trust Registry wish to implement
these new equations shortly.
Aim: To predict the likely impact of the switch from the current Knudson equations
(Am Rev Resp Dis 1983) upon interpretation of annual spirometry measurements.
Methods: The GLI-2012 equations were applied to a subset of cross-sectional data
from Port CF (950 patients; 6−75 years) to calculate FEV1 and FVC as %predicted,
and compared with those calculated from Knudson.
Results: Group results were slightly but signiﬁcantly lower by GLI-2012 vs
Knudson (FEV1 −2.44%, (95% CI −2.29; −2.59) and FVC −4.02% (−3.83; −4.21).
Differences in FEV1 within individuals were far greater, ranging from −12% to 5%.
There was a marked age effect, with Knudson underestimating FEV1% predicted
in younger children and in adults above 50 years of age, but over-estimating in
adolescents, when compared with the rest of the population.
Conclusions: These ﬁndings demonstrate that the planned switch from Knudson
to GLI-2012 will result in minor changes in the population average, but could
markedly impact interpretation within an individual. The new reference values
should aid longitudinal tracking; allow valid interpretation of spirometry in young
children; and provide reassurance to older adults with CF. Importantly, they will
allow easier identiﬁcation of individuals with declining lung function during the
crucial adolescent years.
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Rationale and objectives: Prognostic assessment of adult CF patients has proven
difﬁcult. The 6 minute walk test (6MWT) provides prognostic information in various
respiratory diseases, but only limited data exist in adult CF patients.
Methods: A retrospective study in a single adult CF center in Paris (France). All
consecutive CF adults who performed a 6MWT over a 12 year period were analyzed.
Determinants of a low 6 minute walking distance (6MWD) or a desaturation
(SpO2 90% at any time during the 6MWT) were examined using multivariate
logistic regression analyses. Prognostic value of these variables was assessed by
Kaplan–Meier and Cox analyses.
Results: A 6MWT was performed in 286 CF adults (median age, 28 yr; median
FEV1, 45% predicted) of whom 40 (14%) had lung transplantation and 18 (6%)
died without transplantation during follow-up. Although the 6MWD correlated with
FEV1% predicted, it was markedly different in subjects within the same range of
airﬂow limitation. A 6MWD 475m was established to best predict death or lung
transplantation, using a receiver operating curve analysis. Desaturation during the
6MWT occurred in 29% of patients, exclusively in subjects with an FEV1 60%
predicted. Both a 6MWD 475m and a desaturation during the 6MWT were mostly
found in patients with FEV1 60% predicted and were independent predictors of
death or lung transplantation.
Conclusion: The 6MWT provides prognostic information in CF adults, and should
be performed routinely, especially in subjects with FEV160% predicted.
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Objectives: To examine the determinants of 6MWD and desaturation during the 6
minute walk test in CF adults.
Methods: A retrospective study in a single adult CF center in Paris (France). All
consecutive CF adults who performed a 6MWT over a 12 year period were analyzed
(n = 286 patients). Determinants of a low 6 minute walking distance (6MWD) or
a desaturation (SpO2 90% at any time during the 6MWT) were examined using
multivariate logistic regression analyses.
Results: The median [IQR] 6MWD was 526 [460; 584]m. The 6MWD correlated
with FEV1 % predicted (Pearson r = 0.43; P < 0.001 [PB1]); median 6MWD
were 574m, 522m and 458m in subjects with moderate, severe and very severe
airﬂow limitation, respectively. A low 6MWD (475m) was found in 84 (29%)
patients, including 39/66 (59%) patients with FEV1 <30% predicted, 33/129 (26%)
patients with 30% FEV1 < 60% predicted, and 12/91 (13%) patients with FEV1
60% predicted (P < 0.0001, chi-square test). In multivariate analysis, only FEV1
% predicted and SpO2 at rest were signiﬁcant predictors of 6MWD. Desaturation
during the 6MWT was found in 83 (29%) patients, exclusively in patients with
FEV1 60% predicted. In multivariate analysis, variables associated with desatura-
tion during the 6MWT were SpO2 at rest, FEV1 % predicted, residual volume/total
lung capacity, body mass index, and liver cirrhosis.
Conclusion: Low 6MWD and desaturation during the 6MWT occurred in CF pa-
tients with FEV1 60%. This study suggest that these variables explore different
aspects of the disease in CF adult.
